within Pharmacolibrary.Drugs.ATC.V;

model V09GA03
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 1,
    Cl             = 1.0 / 1000 / 60,
    adminDuration  = 600,
    adminMass      = 740 / 1000000,
    adminCount     = 1,
    Vd             = 0.00047999999999999996,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.016666666666666666,
    Tlag           = 600
  );

  annotation(Documentation(
    info ="<html><body><p>Technetium (99mTc) teboroxime is a radiopharmaceutical tracer previously used in myocardial perfusion imaging to assess coronary artery disease. It is a technetium-labeled boronic acid derivative that demonstrates rapid myocardial uptake and fast washout, which allows for imaging of coronary blood flow. Its use has diminished in recent years and it is not widely available or approved in current clinical practice.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters are reported from studies involving healthy adult subjects undergoing myocardial perfusion imaging.</p><h4>References</h4><ol><li><p>Narra, RK, et al., &amp; Nunn, AD (1992). Absorbed radiation dose to humans from technetium-99m-teboroxime. <i>Journal of nuclear medicine : official publication, Society of Nuclear Medicine</i> 33(1) 88–93. PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/1731003/&quot;>https://pubmed.ncbi.nlm.nih.gov/1731003</a></p></li><li><p>Ohtake, T, et al., &amp; Sugimoto, T (1991). [Clinical application of 99mTc-SQ30,217 myocardial imaging--a study of pharmacokinetics and imaging time]. <i>Kaku igaku. The Japanese journal of nuclear medicine</i> 28(1) 71–82. PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/2020138/&quot;>https://pubmed.ncbi.nlm.nih.gov/2020138</a></p></li><li><p>Stewart, RE, et al., &amp; Rogers, WL (1990). Myocardial clearance kinetics of technetium-99m-SQ30217: a marker of regional myocardial blood flow. <i>Journal of nuclear medicine : official publication, Society of Nuclear Medicine</i> 31(7) 1183–1190. PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/2362197/&quot;>https://pubmed.ncbi.nlm.nih.gov/2362197</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end V09GA03;
